Skip to main content
. 2016 Mar 26;7(17):24860–24870. doi: 10.18632/oncotarget.8391

Figure 3. Mutations discovered using NGS panel.

Figure 3

A. Number of tumors with mutation, B. Distribution of mutations per signaling pathways. C. Representation of EGFR gene with the localization of EGFR mutation detected with routine testing and EGFR mutation detected with NGS panel.